Constructive Biology Limited
Registered name: CONSTRUCTIVE BIOLOGY LIMITED
Constructive Biology Limited made £10.8m revenue and a £525k loss in the year to 31 Dec 2025.
Constructive Biology Limited’s revenue was £10.8m in the year to 31 Dec 2025, with a loss of £525k and 46 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 4 yrs · since 2021
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Nov 2022 | 30 Nov 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | No P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £0 | £10.8m |
| Cost of sales | — | — | £0 | £914k |
| Gross profit | — | — | £0 | £9.9m |
| Operating profit | — | — | −£6.5m | −£2.9m |
| Profit before tax | — | — | −£6m | −£1.6m |
| Profit after tax | — | — | −£5.6m | −£525k |
| Profit (best available) | — | — | −£5.6m | −£525k |
| Employees (average) | 3 | 15 | 28 | 46 |
| Ratios | ||||
| Profit margin | — | — | — | −4.9% |
| Gross margin | — | — | — | 91.5% |
| Revenue per employee | — | — | £0 | £234k |
| Profit per employee | — | — | −£201k | −£11.4k |
| Growth (year on year) | ||||
| Headcount growth | — | ▲400% | ▲86.7% | ▲64.3% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £2.2m | £8.1m | £31.4m | £45.2m |
| Net assets | £3.1m | £9m | £33.1m | £48m |
| Fixed assets | £574k | £616k | £1.5m | £1.7m |
| Current assets | £2.7m | £8.8m | £32.6m | — |
| Debtors | £0 | £2.4k | £80.1k | £0 |
| Source | FullAccounts · bulk data Apr 2024 | FullAccounts · bulk data Apr 2024 | FullAccounts · bulk data Apr 2025 | FullAccounts · bulk data Apr 2026 |
How the business works
- Profit margin
- −4.9%
- Profit ÷ revenue.
- Gross margin
- 91.5%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £234k
- Revenue ÷ average employees.
- Profit per employee
- −£11.4k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 16.2%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 0%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲45%
- Now £48m
- Cash at bank
- ▲44%
- Now £45.2m
- Headcount
- ▲64%
- Now 46
- Deferred income
- —
- Now —
- Fixed assets
- ▲19%
- Now £1.7m
Similar profitable businesses
- Biopharma Process Systems LimitedWinchester · Research and experimental development on biotechnology
- Revenue
- £10.1m
- Profit
- £142k
- Staff
- 66
- Flatiron Health UK LtdST Albans · Research and experimental development on biotechnology
- Revenue
- £9.5m
- Profit
- £239k
- Staff
- 32
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
- Dna Legal LimitedFrome · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £3.2m
- Staff
- 55
- Ligand UK Development LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £8.7m
- Profit
- £6m
- Staff
- —
- Theradex (Europe) LimitedRedhill · Research and experimental development on biotechnology
- Revenue
- £15.2m
- Profit
- £3.1m
- Staff
- 43
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£525k), from the Companies House accounts bulk data published Apr 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.